Article
BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer
2024-05-10
Abstract excerpt
<h4>Background</h4> Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer subtype often treated with radiotherapy (RT). Due to its intrinsic heterogeneity and lack of effective targets, it is crucial to identify novel molecular targets that would increase RT efficacy. Here we demonstrate the role of BUB1 (cell cycle Ser/Thr kinase) in TNBC radioresistance and offer a novel strategy to...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f1aab72f-d74e-54eb-8f0d-66852174c3cc
- DOI
- 10.1101/2024.05.07.592812
